Notochordal cells: A potential therapeutic option for intervertebral disc degeneration

Abstract

Intervertebral disc degeneration (IDD) is a prevalent musculoskeletal degenerative disorder worldwide, and ~40% of chronic low back pain cases are associated with IDD. Although the pathogenesis of IDD remains unclear, the reduction in nucleus pulposus cells (NPCs) and degradation of the extracellular matrix (ECM) are critical factors contributing to IDD. Notochordal cells (NCs), derived from the notochord, which rapidly degrades after birth and is eventually replaced by NPCs, play a crucial role in maintaining ECM homeostasis and preventing NPCs apoptosis. Current treatments for IDD only provide symptomatic relief, while lacking the ability to inhibit or reverse its progression. However, NCs and their secretions possess anti-inflammatory properties and promote NPCs proliferation, leading to ECM formation. Therefore, in recent years, NCs therapy targeting the underlying cause of IDD has emerged as a novel treatment strategy. This article provides a comprehensive review of the latest research progress on NCs for IDD, covering their biological characteristics, specific markers, possible mechanisms involved in IDD and therapeutic effects. It also highlights significant future directions in this field to facilitate further exploration of the pathogenesis of IDD and the development of new therapies based on NCs strategies.

References

[1] Bowles RD, Setton LA. Biomaterials for intervertebral disc regeneration and repair. Biomaterials. 2017;129:54-67.

[2] Chen D, Xia D, Pan Z, et al. Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death Dis. 2016;7(10):e2441.

[3] Bergknut N, Smolders LA, Grinwis GCM, et al. Intervertebral disc degeneration in the dog. Part 1: anatomy and physiology of the intervertebral disc and characteristics of intervertebral disc degeneration. Vet J. 2013;195(3):282-291.

[4] Hutton WC, Ganey TM, Elmer WA, et al. Does long-term compressive loading on the intervertebral disc cause degeneration? Spine. 2000;25(23):2993-3004.

[5] Hayes AJ, Benjamin M, Ralphs JR. Extracellular matrix in development of the intervertebral disc. Matrix Biol. 2001;20(2):107-121.

[6] Li L, He J, Zhang G, et al. Role of caspase family in intervertebral disc degeneration and its therapeutic prospects. Biomolecules. 2022;12(8):1074.

[7] Goo B, Kim S-J, Kim E-J, et al. Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: a protocol for a multicenter, randomized, controlled equivalence trial. Medicine. 2018;97(50):e13684.

[8] Zheng C-J, Chen J. Disc degeneration implies low back pain. Theor Biol Med Model. 2015;12:24.

[9] Golob AL, Wipf JE. Low back pain. Med Clin North Am. 2014;98(3):405-428.

[10] Violante FS, Mattioli S, Bonfiglioli R. Low-back pain. Handb Clin Neurol. 2015;131:397-410.

[11] Bron JL, Helder MN, Meisel H-J, Van Royen BJ, Smit TH. Repair, regenerative and supportive therapies of the annulus fibrosus: achievements and challenges. Eur Spine J. 2009;18(3):301-313.

[12] Chen B-L, Guo J-B, Zhang H-W, et al. Surgical versus non-operative treatment for lumbar disc herniation: a systematic review and meta-analysis. Clin Rehabil. 2018;32(2):146-160.

[13] Fujii K, Yamazaki M, Kang JD, et al. Discogenic Back pain: literature review of definition, diagnosis, and treatment. JBMR Plus. 2019;3(5):e10180.

[14] He X, Li Y, Deng B, et al. The PI3K/AKT signalling pathway in inflammation, cell death and glial scar formation after traumatic spinal cord injury: mechanisms and therapeutic opportunities. Cell Prolif. 2022;55(9):e13275.

[15] Bialas P, Maier C, Klose P, Häuser W. Efficacy and harms of long-term opioid therapy in chronic non-cancer pain: systematic review and meta-analysis of open-label extension trials with a study duration ≥26 weeks. Eur J Pain. 2020;24(2):265-278.

[16] Kamper SJ, Logan G, Copsey B, et al. What is usual care for low back pain? A systematic review of health care provided to patients with low back pain in family practice and emergency departments. Pain. 2020;161(4):694-702.

[17] Ohnishi T, Sudo H, Tsujimoto T, Iwasaki N. Age-related spontaneous lumbar intervertebral disc degeneration in a mouse model. J Orthop Res. 2018;36(1):224-232.

[18] Vo N, Niedernhofer LJ, Nasto LA, et al. An overview of underlying causes and animal models for the study of age-related degenerative disorders of the spine and synovial joints. J Orthop Res. 2013;31(6):831-837.

[19] Ohnishi T, Iwasaki N, Sudo H. Causes of and molecular targets for the treatment of intervertebral disc degeneration: a review. Cell. 2022;11(3):394.

[20] Chen H-W, Zhou J-W, Zhang G-Z, Luo Z-B, Li L, Kang X-W. Emerging role and therapeutic implication of mTOR signalling in intervertebral disc degeneration. Cell Prolif. 2023;56(1):e13338.

[21] Zhang G-Z, Liu M-Q, Chen H-W, et al. NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif. 2021;54(7):e13057.

[22] Alini M, Roughley PJ, Antoniou J, Stoll T, Aebi M. A biological approach to treating disc degeneration: not for today, but maybe for tomorrow. Eur Spine J. 2002;11(Suppl 2):S215-S220.

[23] Binch ALA, Fitzgerald JC, Growney EA, Barry F. Cell-based strategies for IVD repair: clinical progress and translational obstacles. Nat Rev Rheumatol. 2021;17(3):158-175.

[24] DiStefano TJ, Shmukler JO, Danias G, Iatridis JC. The functional role of Interface tissue engineering in annulus Fibrosus repair: bridging mechanisms of hydrogel integration with regenerative outcomes. ACS Biomater Sci Eng. 2020;6(12):6556-6586.

[25] Sloan SR, Wipplinger C, Kirnaz S, et al. Combined nucleus pulposus augmentation and annulus fibrosus repair prevents acute intervertebral disc degeneration after discectomy. Sci Transl Med. 2020;12(534):eaay2380.

[26] Gluais M, Clouet J, Fusellier M, et al. In vitro and in vivo evaluation of an electrospun-aligned microfibrous implant for annulus fibrosus repair. Biomaterials. 2019;205:81-93.

[27] Loibl M, Wuertz-Kozak K, Vadala G, Lang S, Fairbank J, Urban JP. Controversies in regenerative medicine: should intervertebral disc degeneration be treated with mesenchymal stem cells? JOR Spine. 2019;2(1):e1043.

[28] Hwang PY, Jing L, Michael KW, Richardson WJ, Chen J, Setton LA. N-cadherin-mediated signaling regulates cell phenotype for nucleus Pulposus cells of the intervertebral disc. Cell Mol Bioeng. 2015;8(1):51-62.

[29] Hunter CJ, Matyas JR, Duncan NA. The functional significance of cell clusters in the notochordal nucleus pulposus: survival and signaling in the canine intervertebral disc. Spine. 2004;29(10):1099-1104.

[30] Han C, Zhu H. Research progress of nucleus pulposus cells phenotypic markers. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011;25(7):867-870.

[31] Kourakis MJ, Reeves W, Newman-Smith E, Maury B, Abdul-Wajid S, Smith WC. A one-dimensional model of PCP signaling: polarized cell behavior in the notochord of the ascidian Ciona. Dev Biol. 2014;395(1):120-130.

[32] Erwin WM, Islam D, Inman RD, Fehlings MG, Tsui FWL. Notochordal cells protect nucleus pulposus cells from degradation and apoptosis: implications for the mechanisms of intervertebral disc degeneration. Arthritis Res Ther. 2011;13(6):R215.

[33] Aguiar DJ, Johnson SL, Oegema TR. Notochordal cells interact with nucleus pulposus cells: regulation of proteoglycan synthesis. Exp Cell Res. 1999;246(1):129-137.

[34] Bach FC, Poramba-Liyanage DW, Riemers FM, et al. Notochordal cell-based treatment strategies and their potential in intervertebral disc regeneration. Front Cell Dev Biol. 2021;9:780749.

[35] Stemple DL. Structure and function of the notochord: an essential organ for chordate development. Development. 2005;132(11):2503-2512.

[36] Adams DS, Keller R, Koehl MA. The mechanics of notochord elongation, straightening and stiffening in the embryo of Xenopus laevis. Development. 1990;110(1):115-130.

[37] de Bakker BS, de Jong KH, Hagoort J, et al. An interactive three-dimensional digital atlas and quantitative database of human development. Science (New York, NY). 2016;354(6315):aag0053-1-aag0053-8.

[38] de Bree K, de Bakker BS, Oostra R-J. The development of the human notochord. PloS One. 2018;13(10):e0205752.

[39] Dietrich S, Schubert FR, Gruss P. Altered Pax gene expression in murine notochord mutants: the notochord is required to initiate and maintain ventral identity in the somite. Mech Dev. 1993;44(2–3):189-207.

[40] Pourquié O, Coltey M, Teillet MA, Ordahl C, Le Douarin NM. Control of dorsoventral patterning of somitic derivatives by notochord and floor plate. Proc Natl Acad Sci U S A. 1993;90(11):5242-5246.

[41] Rodrigues-Pinto R, Berry A, Piper-Hanley K, Hanley N, Richardson SM, Hoyland JA. Spatiotemporal analysis of putative notochordal cell markers reveals CD24 and keratins 8, 18, and 19 as notochord-specific markers during early human intervertebral disc development. J Orthop Res. 2016;34(8):1327-1340.

[42] Choi K-S, Harfe BD. Hedgehog signaling is required for formation of the notochord sheath and patterning of nuclei pulposi within the intervertebral discs. Proc Natl Acad Sci U S A. 2011;108(23):9484-9489.

[43] Bagwell J, Norman J, Ellis K, et al. Notochord vacuoles absorb compressive bone growth during zebrafish spine formation. Elife. 2020;9:e51221.

[44] Séguin CA, Chan D, Dahia CL, Gazit Z. Latest advances in intervertebral disc development and progenitor cells. JOR Spine. 2018;1(3):e1030.

[45] Lawson L, Harfe BD. Notochord to nucleus Pulposus transition. Curr Osteoporos Rep. 2015;13(5):336-341.

[46] Bach FC, de Vries SAH, Krouwels A, et al. The species-specific regenerative effects of notochordal cell-conditioned medium on chondrocyte-like cells derived from degenerated human intervertebral discs. Eur Cell Mater. 2015;30:132-146.

[47] Hunter CJ, Bianchi S, Cheng P, Muldrew K. Osmoregulatory function of large vacuoles found in notochordal cells of the intervertebral disc running title: an osmoregulatory vacuole. Mol Cell Biomech. 2007;4(4):227-237.

[48] Wuertz K, Urban JPG, Klasen J, et al. Influence of extracellular osmolarity and mechanical stimulation on gene expression of intervertebral disc cells. J Orthop Res. 2007;25(11):1513-1522.

[49] Spillekom S, Smolders LA, Grinwis GCM, et al. Increased osmolarity and cell clustering preserve canine notochordal cell phenotype in culture. Tissue Eng Part C Methods. 2014;20(8):652-662.

[50] Palacio-Mancheno PE, Evashwick-Rogler TW, Laudier DM, Purmessur D, Iatridis JC. Hyperosmolarity induces notochordal cell differentiation with aquaporin3 upregulation and reduced N-cadherin expression. J Orthop Res. 2018;36(2):788-798.

[51] Purmessur D, Guterl CC, Cho SK, et al. Dynamic pressurization induces transition of notochordal cells to a mature phenotype while retaining production of important patterning ligands from development. Arthritis Res Ther. 2013;15(5):R122.

[52] Bian Q, Ma L, Jain A, et al. Mechanosignaling activation of TGFβ maintains intervertebral disc homeostasis. Bone Res. 2017;5:17008.

[53] Guehring T, Wilde G, Sumner M, et al. Notochordal intervertebral disc cells: sensitivity to nutrient deprivation. Arthritis Rheum. 2009;60(4):1026-1034.

[54] Hunter CJ, Matyas JR, Duncan NA. Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison. J Anat. 2004;205(5):357-362.

[55] Richardson SM, Ludwinski FE, Gnanalingham KK, Atkinson RA, Freemont AJ, Hoyland JA. Notochordal and nucleus pulposus marker expression is maintained by sub-populations of adult human nucleus pulposus cells through aging and degeneration. Sci Rep. 2017;7(1):1501.

[56] Gao B, Jiang B, Xing W, Xie Z, Luo Z, Zou W. Discovery and application of postnatal nucleus Pulposus progenitors essential for intervertebral disc homeostasis and degeneration. Adv Sci (Weinh). 2022;9(13):e2104888.

[57] Daly C, Ghosh P, Jenkin G, Oehme D, Goldschlager T. A review of animal models of intervertebral disc degeneration: pathophysiology, regeneration, and translation to the clinic. Biomed Res Int. 2016;2016:5952165.

[58] Alini M, Eisenstein SM, Ito K, et al. Are animal models useful for studying human disc disorders/degeneration? Eur Spine J. 2008;17(1):2-19.

[59] Smolders LA, Bergknut N, Grinwis GCM, et al. Intervertebral disc degeneration in the dog. Part 2: chondrodystrophic and non-chondrodystrophic breeds. Vet J. 2013;195(3):292-299.

[60] Wang W-L, Abramson JH, Ganguly A, Rosenberg AE. The surgical pathology of notochordal remnants in adult intervertebral disks: a report of 3 cases. Am J Surg Pathol. 2008;32(8):1123-1129.

[61] Le Maitre CL, Freemont AJ, Hoyland JA. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007;9(3):R45.

[62] Brown S, Matta A, Erwin M, et al. Cell clusters are indicative of stem cell activity in the degenerate intervertebral disc: can their properties Be manipulated to improve intrinsic repair of the disc? Stem Cells Dev. 2018;27(3):147-165.

[63] Risbud MV, Shapiro IM. Notochordal cells in the adult intervertebral disc: new perspective on an old question. Crit Rev Eukaryot Gene Expr. 2011;21(1):29-41.

[64] Hunter CJ, Matyas JR, Duncan NA. The three-dimensional architecture of the notochordal nucleus pulposus: novel observations on cell structures in the canine intervertebral disc. J Anat. 2003;202(Pt 3):279-291.

[65] Kim JH, Deasy BM, Seo HY, et al. Differentiation of intervertebral notochordal cells through live automated cell imaging system in vitro. Spine. 2009;34(23):2486-2493.

[66] Choi K-S, Cohn MJ, Harfe BD. Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation. Dev Dyn. 2008;237(12):3953-3958.

[67] McCann MR, Tamplin OJ, Rossant J, Séguin CA. Tracing notochord-derived cells using a Noto-cre mouse: implications for intervertebral disc development. Dis Model Mech. 2012;5(1):73-82.

[68] Guehring T, Urban JP, Cui Z, Tirlapur UK. Noninvasive 3D vital imaging and characterization of notochordal cells of the intervertebral disc by femtosecond near-infrared two-photon laser scanning microscopy and spatial-volume rendering. Microsc Res Tech. 2008;71(4):298-304.

[69] Ellis K, Bagwell J, Bagnat M. Notochord vacuoles are lysosome-related organelles that function in axis and spine morphogenesis. J Cell Biol. 2013;200(5):667-679.

[70] Deng W, Nies F, Feuer A, Bocina I, Oliver D, Jiang D. Anion translocation through an Slc26 transporter mediates lumen expansion during tubulogenesis. Proc Natl Acad Sci U S A. 2013;110(37):14972-14977.

[71] Hong X, Zhang C, Wang F, Wu X-T. Large cytoplasmic vacuoles within Notochordal nucleus Pulposus cells: a possible regulator of intracellular pressure that shapes the cytoskeleton and controls proliferation. Cells Tissues Organs. 2018;206(1–2):9-15.

[72] Yasuoka Y. Morphogenetic mechanisms forming the notochord rod: the turgor pressure-sheath strength model. Dev Growth Differ. 2020;62(6):379-390.

[73] Sinha B, Köster D, Ruez R, et al. Cells respond to mechanical stress by rapid disassembly of caveolae. Cell. 2011;144(3):402-413.

[74] Nixon SJ, Carter A, Wegner J, et al. Caveolin-1 is required for lateral line neuromast and notochord development. J Cell Sci. 2007;120(Pt 13):2151-2161.

[75] Hunter CJ, Matyas JR, Duncan NA. The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. Tissue Eng. 2003;9(4):667-677.

[76] Risbud MV, Schoepflin ZR, Mwale F, et al. Defining the phenotype of young healthy nucleus pulposus cells: recommendations of the spine research interest group at the 2014 annual ORS meeting. J Orthop Res. 2015;33(3):283-293.

[77] Rodrigues-Pinto R, Richardson SM, Hoyland JA. An understanding of intervertebral disc development, maturation and cell phenotype provides clues to direct cell-based tissue regeneration therapies for disc degeneration. Eur Spine J. 2014;23(9):1803-1814.

[78] Rutges JPHJ, Nikkels PGJ, Oner FC, et al. The presence of extracellular matrix degrading metalloproteinases during fetal development of the intervertebral disc. Eur Spine J. 2010;19(8):1340-1346.

[79] Shu C, Smith SS, Little CB, Melrose J. Comparative immunolocalisation of perlecan, heparan sulphate, fibroblast growth factor-18, and fibroblast growth factor receptor-3 and their prospective roles in chondrogenic and osteogenic development of the human foetal spine. Eur Spine J. 2013;22(8):1774-1784.

[80] Smith SM, Whitelock JM, Iozzo RV, Little CB, Melrose J. Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development. Histochem Cell Biol. 2009;132(5):491-503.

[81] Hayes AJ, Smith SM, Melrose J. Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc. Histochem Cell Biol. 2013;139(1):1-11.

[82] Götz W, Kasper M, Fischer G, Herken R. Intermediate filament typing of the human embryonic and fetal notochord. Cell Tissue Res. 1995;280(2):455-462.

[83] Sun Z, Wang H-Q, Liu Z-H, et al. Down-regulated CK8 expression in human intervertebral disc degeneration. Int J Med Sci. 2013;10(8):948-956.

[84] Minogue BM, Richardson SM, Zeef LAH, Freemont AJ, Hoyland JA. Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum. 2010;62(12):3695-3705.

[85] Weiler C, Nerlich AG, Schaaf R, Bachmeier BE, Wuertz K, Boos N. Immunohistochemical identification of notochordal markers in cells in the aging human lumbar intervertebral disc. Eur Spine J. 2010;19(10):1761-1770.

[86] Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA. Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res Ther. 2010;12(1):R22.

[87] Anderson DG, Izzo MW, Hall DJ, et al. Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine. 2002;27(12):1291-1296.

[88] Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1):11-24.

[89] Chen J, Lee EJ, Jing L, Christoforou N, Leong KW, Setton LA. Differentiation of mouse induced pluripotent stem cells (iPSCs) into nucleus pulposus-like cells in vitro. PloS One. 2013;8(9):e75548.

[90] Bruce J, Symington FW, McKearn TJ, Sprent J. A monoclonal antibody discriminating between subsets of T and B cells. J Immunol. 1981;127(6):2496-2501.

[91] Fujita N, Miyamoto T, Imai J-i, et al. CD24 is expressed specifically in the nucleus pulposus of intervertebral discs. Biochem Biophys Res Commun. 2005;338(4):1890-1896.

[92] Tang X, Jing L, Chen J. Changes in the molecular phenotype of nucleus pulposus cells with intervertebral disc aging. PloS One. 2012;7(12):e52020.

[93] Mori K, Chano T, Kushima R, Hukuda S, Okabe H. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity. Virchows Arch. 2002;440(2):123-127.

[94] Takahashi H, Hotta K, Erives A, et al. Brachyury downstream notochord differentiation in the ascidian embryo. Genes Dev. 1999;13(12):1519-1523.

[95] Saggese T, Redey P, McGlashan SR. Same-species phenotypic comparison of notochordal and mature nucleus pulposus cells. Eur Spine J. 2015;24(9):1976-1985.

[96] Liu Y, Fu S, Rahaman MN, Mao JJ, Bal BS. Native nucleus pulposus tissue matrix promotes notochordal differentiation of human induced pluripotent stem cells with potential for treating intervertebral disc degeneration. J Biomed Mater Res A. 2015;103(3):1053-1059.

[97] Götz W, Kasper M, Miosge N, Hughes RC. Detection and distribution of the carbohydrate binding protein galectin-3 in human notochord, intervertebral disc and chordoma. Differentiation. 1997;62(3):149-157.

[98] Oguz E, Tsai T-T, Di Martino A, et al. Galectin-3 expression in the intervertebral disc: a useful marker of the notochord phenotype? Spine. 2007;32(1):9-16.

[99] Resutek L, Hsieh AH. The vacuolated morphology of chordoma cells is dependent on cytokeratin intermediate filaments. J Cell Physiol. 2019;234(4):3458-3468.

[100] Stosiek P, Kasper M, Karsten U. Expression of cytokeratin and vimentin in nucleus pulposus cells. Differentiation. 1988;39(1):78-81.

[101] Sagstad A, Grotmol S, Kryvi H, et al. Identification of vimentin-and elastin-like transcripts specifically expressed in developing notochord of Atlantic salmon (Salmo salar L.). Cell Tissue Res. 2011;346(2):191-202.

[102] Chen J, Yan W, Setton LA. Molecular phenotypes of notochordal cells purified from immature nucleus pulposus. Eur Spine J. 2006;15(Suppl 3):S303-S311.

[103] Sakai D, Schol J, Bach FC, et al. Successful fishing for nucleus pulposus progenitor cells of the intervertebral disc across species. JOR Spine. 2018;1(2):e1018.

[104] Sakai D, Nakamura Y, Nakai T, et al. Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat Commun. 2012;3:1264.

[105] Wang S, Furmanek T, Kryvi H, et al. Transcriptome sequencing of Atlantic salmon (Salmo salar L.) notochord prior to development of the vertebrae provides clues to regulation of positional fate, chordoblast lineage and mineralisation. BMC Genomics. 2014;15:141.

[106] Snuggs JW, Day RE, Bach FC, et al. Aquaporin expression in the human and canine intervertebral disc during maturation and degeneration. JOR Spine. 2019;2(1):e1049.

[107] Erwin WM, Ashman K, O'Donnel P, Inman RD. Nucleus pulposus notochord cells secrete connective tissue growth factor and up-regulate proteoglycan expression by intervertebral disc chondrocytes. Arthritis Rheum. 2006;54(12):3859-3867.

[108] Poiraudeau S, Monteiro I, Anract P, Blanchard O, Revel M, Corvol MT. Phenotypic characteristics of rabbit intervertebral disc cells. Comparison with cartilage cells from the same animals. Spine. 1999;24(9):837-844.

[109] Cappello R, Bird JLE, Pfeiffer D, Bayliss MT, Dudhia J. Notochordal cell produce and assemble extracellular matrix in a distinct manner, which may be responsible for the maintenance of healthy nucleus pulposus. Spine. 2006;31(8):873-882.

[110] Mwale F, Wang HT, Petit A, et al. The effect of novel nitrogen-rich plasma polymer coatings on the phenotypic profile of notochordal cells. Biomed Eng Online. 2007;6:33.

[111] Mahmoud M, Kokozidou M, Auffarth A, Schulze-Tanzil G. The relationship between diabetes mellitus type II and intervertebral disc degeneration in diabetic rodent models: a systematic and comprehensive review. Cell. 2020;9(10):2208.

[112] Park E-Y, Park J-B. Dose- and time-dependent effect of high glucose concentration on viability of notochordal cells and expression of matrix degrading and fibrotic enzymes. Int Orthop. 2013;37(6):1179-1186.

[113] Humphreys MD, Ward L, Richardson SM, Hoyland JA. An optimized culture system for notochordal cell expansion with retention of phenotype. JOR Spine. 2018;1(3):e1028.

[114] Urban JPG, Smith S, Fairbank JCT. Nutrition of the intervertebral disc. Spine. 2004;29(23):2700-2709.

[115] Smolders LA, Meij BP, Riemers FM, et al. Canonical Wnt signaling in the notochordal cell is upregulated in early intervertebral disk degeneration. J Orthop Res. 2012;30(6):950-957.

[116] Erwin WM, Las Heras F, Islam D, Fehlings MG, Inman RD. The regenerative capacity of the notochordal cell: tissue constructs generated in vitro under hypoxic conditions. J Neurosurg Spine. 2009;10(6):513-521.

[117] Omlor GW, Nerlich AG, Tirlapur UK, Urban JP, Guehring T. Loss of notochordal cell phenotype in 3D-cell cultures: implications for disc physiology and disc repair. Arch Orthop Trauma Surg. 2014;134(12):1673-1681.

[118] Gilchrist CL, Darling EM, Chen J, Setton LA. Extracellular matrix ligand and stiffness modulate immature nucleus pulposus cell-cell interactions. PloS One. 2011;6(11):e27170.

[119] Fearing BV, Jing L, Barcellona MN, et al. Mechanosensitive transcriptional coactivators MRTF-A and YAP/TAZ regulate nucleus pulposus cell phenotype through cell shape. FASEB J. 2019;33(12):14022-14035.

[120] Barcellona MN, Speer JE, Fearing BV, et al. Control of adhesive ligand density for modulation of nucleus pulposus cell phenotype. Biomaterials. 2020;250:120057.

[121] Bridgen DT, Fearing BV, Jing L, et al. Regulation of human nucleus pulposus cells by peptide-coupled substrates. Acta Biomater. 2017;55:100-108.

[122] Weigel DP, Marsh JL. High-energy fractures of the tibial plateau. Knee function after longer follow-up. J Bone Joint Surg Am. 2002;84(9):1541-1551.

[123] Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75(6):1169-1178.

[124] Nagata S, Golstein P. The Fas death factor. Science (New York, NY). 1995;267(5203):1449-1456.

[125] Krammer PH. CD95's deadly mission in the immune system. Nature. 2000;407(6805):789-795.

[126] Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet. 1999;33:29-55.

[127] Green DR, Ferguson TA. The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol. 2001;2(12):917-924.

[128] Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17(6):1675-1687.

[129] Xu H, Li J, Fei Q, Jiang L. Contribution of immune cells to intervertebral disc degeneration and the potential of immunotherapy. Connect Tissue Res. 2023;64:413-427.

[130] Kim K-W, Kim Y-S, Ha K-Y, et al. An autocrine or paracrine Fas-mediated counterattack: a potential mechanism for apoptosis of notochordal cells in intact rat nucleus pulposus. Spine. 2005;30(11):1247-1251.

[131] Mikulak SA, Gold SM, Zinar DM. Small wire external fixation of high energy tibial plateau fractures. Clin Orthop Relat Res. 1998;356:230-238.

[132] Inui Y, Nishida K, Doita M, et al. Fas-ligand expression on nucleus pulposus begins in developing embryo. Spine. 2004;29(21):2365-2369.

[133] Takada T, Nishida K, Doita M, Kurosaka M. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine. 2002;27(14):1526-1530.

[134] Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (New York, NY). 1995;270(5239):1189-1192.

[135] Park JB, Chang H, Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine. 2001;26(6):618-621.

[136] Tan KH, Hunziker W. Compartmentalization of Fas and Fas ligand may prevent auto- or paracrine apoptosis in epithelial cells. Exp Cell Res. 2003;284(2):283-290.

[137] Kim K-W, Ha K-Y, Lee J-S, Rhyu K-W, An HS, Woo Y-K. The apoptotic effects of oxidative stress and antiapoptotic effects of caspase inhibitors on rat notochordal cells. Spine. 2007;32(22):2443-2448.

[138] Suhl K-H, Park J-B, Park E-Y, Rhee S-K. Effect of nerve growth factor and its transforming tyrosine kinase protein and low-affinity nerve growth factor receptors on apoptosis of notochordal cells. Int Orthop. 2012;36(8):1747-1753.

[139] Yang F, Leung VYL, Luk KDK, Chan D, Cheung KMC. Injury-induced sequential transformation of notochordal nucleus pulposus to chondrogenic and fibrocartilaginous phenotype in the mouse. J Pathol. 2009;218(1):113-121.

[140] Martin A, Wohlgenannt O, Prenn M, von Strempel A. Post-traumatic osteoarthritis of the knee: special indication for navigated TKA. Unfallchirurg. 2008;111(9):754-758.

[141] Erwin WM, Inman RD. Notochord cells regulate intervertebral disc chondrocyte proteoglycan production and cell proliferation. Spine. 2006;31(10):1094-1099.

[142] Yamamoto M, Morita R, Mizoguchi T, et al. Mib-Jag1-notch signalling regulates patterning and structural roles of the notochord by controlling cell-fate decisions. Development. 2010;137(15):2527-2537.

[143] Cornejo MC, Cho SK, Giannarelli C, Iatridis JC, Purmessur D. Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines. Osteoarthr Cartil. 2015;23(3):487-496.

[144] Won H-Y, Park J-B, Park E-Y, Riew KD. Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats. J Neurosurg Spine. 2009;11(6):741-748.

[145] Purmessur D, Cornejo MC, Cho SK, Hecht AC, Iatridis JC. Notochordal cell-derived therapeutic strategies for discogenic back pain. Global Spine J. 2013;3(3):201-218.

[146] Ma K, Wu Y, Wang B, Yang S, Wei Y, Shao Z. Effect of a synthetic link N peptide nanofiber scaffold on the matrix deposition of aggrecan and type II collagen in rabbit notochordal cells. J Mater Sci Mater Med. 2013;24(2):405-415.

[147] Gantenbein-Ritter B, Chan SCW. The evolutionary importance of cell ratio between notochordal and nucleus pulposus cells: an experimental 3-D co-culture study. Eur Spine J. 2012;21(Suppl 6):S819-S825.

[148] Gantenbein B, Calandriello E, Wuertz-Kozak K, Benneker LM, Keel MJB, Chan SCW. Activation of intervertebral disc cells by co-culture with notochordal cells, conditioned medium and hypoxia. BMC Musculoskelet Disord. 2014;15:422.

[149] Potier E, Ito K. Using notochordal cells of developmental origin to stimulate nucleus pulposus cells and bone marrow stromal cells for intervertebral disc regeneration. Eur Spine J. 2014;23(3):679-688.

[150] Potier E, de Vries S, van Doeselaar M, Ito K. Potential application of notochordal cells for intervertebral disc regeneration: an in vitro assessment. Eur Cell Mater. 2014;28:68-80.

[151] Arkesteijn ITM, Smolders LA, Spillekom S, et al. Effect of coculturing canine notochordal, nucleus pulposus and mesenchymal stromal cells for intervertebral disc regeneration. Arthritis Res Ther. 2015;17(1):60.

[152] Kim JH, Moon HJ, Lee JH, Kim JH, Kwon TH, Park YK. Rabbit notochordal cells modulate the expression of inflammatory mediators by human annulus fibrosus cells cocultured with activated macrophage-like THP-1 cells. Spine. 2012;37(22):1856-1864.

[153] Bai X-D, Li X-C, Chen J-H, et al. Coculture with partial digestion Notochordal cell-rich nucleus Pulposus tissue activates degenerative human nucleus Pulposus cells. Tissue Eng Part A. 2017;23(15–16):837-846.

[154] Abbott RD, Purmessur D, Monsey RD, Iatridis JC. Regenerative potential of TGFβ3 + Dex and notochordal cell conditioned media on degenerated human intervertebral disc cells. J Orthop Res. 2012;30(3):482-488.

[155] de Vries SAH, Potier E, van Doeselaar M, Meij BP, Tryfonidou MA, Ito K. Conditioned medium derived from notochordal cell-rich nucleus pulposus tissue stimulates matrix production by canine nucleus pulposus cells and bone marrow-derived stromal cells. Tissue Eng Part A. 2015;21(5–6):1077-1084.

[156] Bach FC, de Vries SA, Riemers FM, et al. Soluble and pelletable factors in porcine, canine and human notochordal cell-conditioned medium: implications for IVD regeneration. Eur Cell Mater. 2016;32:163-180.

[157] Mehrkens A, Matta A, Karim MZ, et al. Notochordal cell-derived conditioned medium protects human nucleus pulposus cells from stress-induced apoptosis. Spine J. 2017;17(4):579-588.

[158] Korecki CL, Taboas JM, Tuan RS, Iatridis JC. Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther. 2010;1(2):18.

[159] Purmessur D, Schek RM, Abbott RD, Ballif BA, Godburn KE, Iatridis JC. Notochordal conditioned media from tissue increases proteoglycan accumulation and promotes a healthy nucleus pulposus phenotype in human mesenchymal stem cells. Arthritis Res Ther. 2011;13(3):R81.

[160] Boyd LM, Chen J, Kraus VB, Setton LA. Conditioned medium differentially regulates matrix protein gene expression in cells of the intervertebral disc. Spine. 2004;29(20):2217-2222.

[161] Kim K-W, Ha K-Y, Lee J-S, et al. Notochordal cells stimulate migration of cartilage end plate chondrocytes of the intervertebral disc in in vitro cell migration assays. Spine J. 2009;9(4):323-329.

[162] Müller S, Acevedo L, Wang X, et al. Notochordal cell conditioned medium (NCCM) regenerates end-stage human osteoarthritic articular chondrocytes and promotes a healthy phenotype. Arthritis Res Ther. 2016;18(1):125.

[163] Bach F, Libregts S, Creemers L, et al. Notochordal-cell derived extracellular vesicles exert regenerative effects on canine and human nucleus pulposus cells. Oncotarget. 2017;8(51):88845-88856.

[164] de Vries SAH, van Doeselaar M, Meij BP, Tryfonidou MA, Ito K. The stimulatory effect of Notochordal cell-conditioned medium in a nucleus Pulposus explant culture. Tissue Eng Part A. 2016;22(1–2):103-110.

[165] Matta A, Karim MZ, Isenman DE, Erwin WM. Molecular therapy for degenerative disc disease: clues from Secretome analysis of the Notochordal cell-rich nucleus Pulposus. Sci Rep. 2017;7:45623.

[166] de Vries S, Mv D, Meij B, Tryfonidou M, Ito K. Notochordal cell matrix As a therapeutic agent for intervertebral disc regeneration. Tissue Eng Part A. 2019;25(11–12):830-841.

[167] Purmessur D, Cornejo MC, Cho SK, et al. Intact glycosaminoglycans from intervertebral disc-derived notochordal cell-conditioned media inhibit neurite growth while maintaining neuronal cell viability. Spine J. 2015;15(5):1060-1069.

[168] Tortorella MD, Arner EC, Hills R, et al. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem. 2004;279(17):17554-17561.

[169] Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest. 2001;107(8):929-934.

[170] Gygi D, Zumstein P, Grossenbacher D, Altwegg L, Lüscher TF, Gehring H. Human connective tissue growth factor expressed in Escherichia coli is a non-mitogenic inhibitor of apoptosis. Biochem Biophys Res Commun. 2003;311(3):685-690.

[171] Croci S, Landuzzi L, Astolfi A, et al. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res. 2004;64(5):1730-1736.

[172] Nakanishi T, Nishida T, Shimo T, et al. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology. 2000;141(1):264-273.

[173] Bagnard D, Lohrum M, Uziel D, Püschel AW, Bolz J. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development. 1998;125(24):5043-5053.

[174] Binch ALA, Cole AA, Breakwell LM, et al. Class 3 semaphorins expression and association with innervation and angiogenesis within the degenerate human intervertebral disc. Oncotarget. 2015;6(21):18338-18354.

[175] Matta A, Karim MZ, Gerami H, et al. NTG-101: a novel molecular therapy that halts the progression of degenerative disc disease. Sci Rep. 2018;8(1):16809.

[176] Zhao H, Wei J, Sun J. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy. Int Immunopharmacol. 2020;89:107101.

[177] Chen Z, Zhang N, Chu HY, et al. Connective tissue growth factor: from molecular understandings to drug discovery. Front Cell Dev Biol. 2020;8:593269.

[178] Bach FC, Miranda-Bedate A, van Heel FWM, et al. Bone morphogenetic Protein-2, but not mesenchymal stromal cells, exert regenerative effects on canine and human nucleus Pulposus cells. Tissue Eng Part A. 2017;23(5–6):233-242.

[179] Piazza N, Dehghani M, Gaborski TR, Wuertz-Kozak K. Therapeutic potential of extracellular vesicles in degenerative diseases of the intervertebral disc. Front Bioeng Biotechnol. 2020;8:311.

[180] Malda J, Boere J, van de Lest CHA, van Weeren PR, Wauben MHM. Extracellular vesicles—new tool for joint repair and regeneration. Nat Rev Rheumatol. 2016;12(4):243-249.

[181] Caldeira J, Santa C, Osório H, et al. Matrisome profiling during intervertebral disc development and ageing. Sci Rep. 2017;7(1):11629.

[182] Vyas N, Walvekar A, Tate D, et al. Vertebrate hedgehog is secreted on two types of extracellular vesicles with different signaling properties. Sci Rep. 2014;4:7357.

[183] Erwin WM. The notochord, Notochordal cell and CTGF/CCN-2: ongoing activity from development through maturation. J Cell Commun Signal. 2008;2(3–4):59-65.

[184] Ali R, Le Maitre CL, Richardson SM, Hoyland JA, Freemont AJ. Connective tissue growth factor expression in human intervertebral disc: implications for angiogenesis in intervertebral disc degeneration. Biotech Histochem. 2008;83(5):239-245.

[185] Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO. Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev. 2012;64(12):1063-1077.

[186] Bach FC, Tellegen AR, Beukers M, et al. Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside. Oncotarget. 2018;9(41):26507-26526.

[187] Pei M, Shoukry M, Li J, Daffner SD, France JC, Emery SE. Modulation of in vitro microenvironment facilitates synovium-derived stem cell-based nucleus pulposus tissue regeneration. Spine. 2012;37(18):1538-1547.

[188] de Vries SAH, van Doeselaar M, Meij BP, Tryfonidou MA, Ito K. Notochordal cell matrix: An inhibitor of neurite and blood vessel growth? J Orthop Res. 2018;36(12):3188-3195.

[189] Wachs RA, Hoogenboezem EN, Huda HI, Xin S, Porvasnik SL, Schmidt CE. Creation of an injectable in situ gelling native extracellular matrix for nucleus pulposus tissue engineering. Spine J. 2017;17(3):435-444.

[190] Mercuri JJ, Gill SS, Simionescu DT. Novel tissue-derived biomimetic scaffold for regenerating the human nucleus pulposus. J Biomed Mater Res A. 2011;96(2):422-435.

[191] Mercuri JJ, Patnaik S, Dion G, Gill SS, Liao J, Simionescu DT. Regenerative potential of decellularized porcine nucleus pulposus hydrogel scaffolds: stem cell differentiation, matrix remodeling, and biocompatibility studies. Tissue Eng Part A. 2013;19(7–8):952-966.

[192] Xu J, Liu S, Wang S, et al. Decellularised nucleus pulposus as a potential biologic scaffold for disc tissue engineering. Mater Sci Eng C Mater Biol Appl. 2019;99:1213-1225.

[193] Zhou X, Wang J, Huang X, et al. Injectable decellularized nucleus pulposus-based cell delivery system for differentiation of adipose-derived stem cells and nucleus pulposus regeneration. Acta Biomater. 2018;81:115-128.

[194] Caterson B. Fell-Muir lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others. Int J Exp Pathol. 2012;93(1):1-10.

[195] Konertz W, Angeli E, Tarusinov G, et al. Right ventricular outflow tract reconstruction with decellularized porcine xenografts in patients with congenital heart disease. J Heart Valve Dis. 2011;20(3):341-347.

[196] Stone KR, Abdel-Motal UM, Walgenbach AW, Turek TJ, Galili U. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation. 2007;83(2):211-219.

[197] van der Laan LJ, Lockey C, Griffeth BC, et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature. 2000;407(6800):90-94.

[198] Wong ML, Griffiths LG. Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization. Acta Biomater. 2014;10(5):1806-1816.

[199] Park S, Kim W-H, Choi S-Y, Kim Y-J. Removal of alpha-gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase a. J Korean Med Sci. 2009;24(6):1126-1131.

[200] Dreyer F, Baur A. Biogenesis and functions of exosomes and extracellular vesicles. Methods Mol Biol. 2016;1448:201-216.

[201] Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7(3):297-303.

[202] Lema DA, Burlingham WJ. Role of exosomes in tumour and transplant immune regulation. Scand J Immunol. 2019;90(5):e12807.

[203] Asghar S, Litherland GJ, Lockhart JC, Goodyear CS, Crilly A. Exosomes in intercellular communication and implications for osteoarthritis. Rheumatology (Oxford). 2020;59(1):57-68.

[204] Rodrigues-Pinto R, Ward L, Humphreys M, et al. Human notochordal cell transcriptome unveils potential regulators of cell function in the developing intervertebral disc. Sci Rep. 2018;8(1):12866.

[205] Sun Z, Liu B, Liu Z-H, et al. Notochordal-cell-derived exosomes induced by compressive load inhibit angiogenesis via the miR-140-5p/Wnt/β-catenin Axis. Mol Ther Nucleic Acids. 2020;22:1092-1106.

[206] Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.

[207] Zeng Z, Li Y, Pan Y, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9(1):5395.

[208] Rothman AMK, Arnold ND, Pickworth JA, et al. MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension. J Clin Invest. 2016;126(7):2495-2508.

[209] Fang Z, Yin S, Sun R, et al. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Mol Cancer. 2017;16(1):139.

[210] Lan H, Chen W, He G, Yang S. miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. Biomed Pharmacother. 2015;75:117-122.

[211] Zhang Q, Lou Y, Zhang J, et al. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer. Mol Cancer. 2017;16(1):119.

[212] Hübner K, Cabochette P, Diéguez-Hurtado R, et al. Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling. Nat Commun. 2018;9(1):4860.

[213] Perugorria MJ, Olaizola P, Labiano I, et al. Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(2):121-136.

[214] Schaefer KN, Peifer M. Wnt/Beta-catenin signaling regulation and a role for biomolecular condensates. Dev Cell. 2019;48(4):429-444.

[215] Stefater JA, Lewkowich I, Rao S, et al. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature. 2011;474(7352):511-515.

[216] Franco CA, Jones ML, Bernabeu MO, et al. Non-canonical Wnt signalling modulates the endothelial shear stress flow sensor in vascular remodelling. Elife. 2016;5:e07727.

[217] Liu Y, Zhang H, Yan L, et al. MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells. J Mol Cell Cardiol. 2018;121:36-50.

[218] Joo HS, Suh JH, Lee HJ, Bang ES, Lee JM. Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int J Mol Sci. 2020;21(3):727.

[219] Liao Z, Luo R, Li G, et al. Exosomes from mesenchymal stem cells modulate endoplasmic reticulum stress to protect against nucleus pulposus cell death and ameliorate intervertebral disc degeneration in vivo. Theranostics. 2019;9(14):4084-4100.

[220] Xia C, Zeng Z, Fang B, et al. Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects. Free Radic Biol Med. 2019;143:1-15.

[221] Zhu L, Shi Y, Liu L, Wang H, Shen P, Yang H. Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases. Cell Cycle. 2020;19(14):1727-1739.

[222] Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209(2):157-165.

[223] Bakker SH, Jacobs WCH, Pondaag W, et al. Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival. Eur Spine J. 2018;27(12):3043-3058.

[224] McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12(1):1-11.

[225] McCann MR, Séguin CA. Notochord cells in intervertebral disc development and degeneration. J Dev Biol. 2016;4(1):3.

[226] Yamaguchi T, Suzuki S, Ishiiwa H, Ueda Y. Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas? Histopathology. 2004;44(6):597-602.

[227] Stigen Ø, Ottesen N, Gamlem H, Åkesson CP. Cervical chondroid chordoma in a standard dachshund: a case report. Acta Vet Scand. 2011;53(1):55.

[228] Gruber A, Kneissl S, Vidoni B, Url A. Cervical spinal chordoma with chondromatous component in a dog. Vet Pathol. 2008;45(5):650-653.

[229] Peng B, DePalma MJ. Cervical disc degeneration and neck pain. J Pain Res. 2018;11:2853-2857.

[230] Rustenburg CME, Emanuel KS, Peeters M, Lems WF, Vergroesen P-PA, Smit TH. Osteoarthritis and intervertebral disc degeneration: quite different, quite similar. JOR Spine. 2018;1(4):e1033.

[231] Rutges JPHJ, Duit RA, Kummer JA, et al. Hypertrophic differentiation and calcification during intervertebral disc degeneration. Osteoarthr Cartil. 2010;18(11):1487-1495.

[232] de Vries SAH, van Doeselaar M, Kaper HJ, Sharma PK, Ito K. Notochordal cell matrix as a bioactive lubricant for the osteoarthritic joint. Sci Rep. 2018;8(1):8875.

[233] Nesti LJ, Li W-J, Shanti RM, et al. Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A. 2008;14(9):1527-1537.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.